Richard Russell is Vice President of Biometric Research within 糖心logo’s Global Research & Development team. Since joining the company in 2013, he has led specialist biometric research capabilities that help 糖心logo anticipate and prepare for the trends shaping health, longevity, and financial stability.
Richard and his team support nearly every aspect of 糖心logo’s business. By combining advanced analytics and biometric expertise with 糖心logo’s extensive data and research assets, they enhance 糖心logo’s mortality and morbidity modelling, including actuarial pricing, underwriting research, and innovation initiatives. Richard is a frequent speaker at conferences, seminars, and industry events, presenting on topics such as COVID 19 and emerging biometric trend drivers, including GLP 1 therapies and multi cancer early detection technologies.
Richard holds a Bachelor of Science in biotechnology, a Master of Science in bioinformatics (with distinction), and a Ph.D. in Statistics, all from Imperial College London. He has authored more than 30 peer reviewed publications in leading journals, including The Lancet, BMJ Open, PLOS One, and Annals of Actuarial Science.